Company
TELA Bio
Nasdaq: TELA
Commercial-stage medical technology company headquartered in Malvern, Pennsylvania, founded 2012. Designs and markets tissue reinforcement materials for hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.
1 story
Regulatory News has published 1 story about TELA Bio on 7 October 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 7 October 2026.
This page is generated from Regulatory News’ editorial coverage of TELA Bio. It is not an advertisement.
On the record
- Company
- TELA Bio, Inc. (Nasdaq: TELA)
- Headquarters
- Malvern, Pennsylvania
- Founded
- 2012
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, Liora Monofilament Scaffold
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
